Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Efsubaglutide Alfa

Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery

Shanghai Yinnuo Pharmaceutical Technology Co · Phase 4 · Recruiting · Enrollment 60

NCT07163650

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Efsubaglutide Alfa groupn/rn/rn/rn/r
control groupn/rn/rn/rn/r

Not shown

  • Efsubaglutide Alfa group: endpoint not reported
  • control group: endpoint not reported